What is the share price of Sotac Pharmaceuticals Ltd (SOTAC) today?
The share price of SOTAC as on 11th July 2025 is ₹129.85. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sotac Pharmaceuticals Ltd (SOTAC) share?
The past returns of Sotac Pharmaceuticals Ltd (SOTAC) share are- Past 1 week: N/A%
- Past 1 month: 3.34%
- Past 3 months: 9.39%
- Past 6 months: 14.61%
- Past 1 year: -23.17%
- Past 3 years: N/A%
- Past 5 years: 7.54%
What are the peers or stocks similar to Sotac Pharmaceuticals Ltd (SOTAC)?
The peers or stocks similar to Sotac Pharmaceuticals Ltd (SOTAC) include:What is the market cap of Sotac Pharmaceuticals Ltd (SOTAC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sotac Pharmaceuticals Ltd (SOTAC) is ₹143.48 Cr as of 11th July 2025.What is the 52 week high and low of Sotac Pharmaceuticals Ltd (SOTAC) share?
The 52-week high of Sotac Pharmaceuticals Ltd (SOTAC) is ₹202.80 and the 52-week low is ₹88.05.What is the PE and PB ratio of Sotac Pharmaceuticals Ltd (SOTAC) stock?
The P/E (price-to-earnings) ratio of Sotac Pharmaceuticals Ltd (SOTAC) is 17.91. The P/B (price-to-book) ratio is 2.91.Which sector does Sotac Pharmaceuticals Ltd (SOTAC) belong to?
Sotac Pharmaceuticals Ltd (SOTAC) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Sotac Pharmaceuticals Ltd (SOTAC) shares?
You can directly buy Sotac Pharmaceuticals Ltd (SOTAC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sotac Pharmaceuticals Ltd
SOTAC Share Price
129.850.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SOTAC Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SOTAC Performance & Key Metrics
SOTAC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 31.96 | 2.91 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.68 | 6.41 | 0.79% |
SOTAC Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SOTAC Company Profile
The Company specializes in the manufacturing of a range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-Lactam syrup, and external preparations.
SUNPHARMA
PE Ratio
36.71
36.71
1Y Return
5.71%
5.71%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.75
22.75
1Y Return
1.39%
1.39%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
58.69
58.69
1Y Return
12.03%
12.03%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
53.44
53.44
1Y Return
21.78%
21.78%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.46
18.46
1Y Return
4.87%
4.87%
Buy Reco %
50.00
50.00
SOTAC Forecast
SOTAC Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SOTAC
SOTAC
Income
Balance Sheet
Cash Flow
Annual Normal View
SOTAC Income Statement
SOTAC Income Statement
Annual Normal View
| Financial Year | FY 2023 | FY 2024 | FY 2025 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 77.83 | 104.32 | 100.88 | 106.45 | ||||
Raw Materials | 61.68 | 80.37 | 83.35 | 96.60 | ||||
| Power & Fuel Cost | 1.37 | 1.98 | ||||||
| Employee Cost | 2.58 | 2.05 | ||||||
| Selling & Administrative Expenses | 4.23 | 4.39 | ||||||
| Operating & Other expenses | -0.27 | 6.72 | ||||||
EBITDA | 8.24 | 8.81 | 17.53 | 9.85 | ||||
| Depreciation/Amortization | 2.28 | 3.10 | 3.84 | 3.20 | ||||
| PBIT | 5.96 | 5.71 | 13.69 | 6.65 | ||||
| Interest & Other Items | 2.04 | 1.74 | 2.58 | 2.36 | ||||
| PBT | 3.92 | 3.97 | 11.11 | 4.29 | ||||
| Taxes & Other Items | 1.05 | -0.31 | 3.10 | -0.20 | ||||
| Net Income | 2.87 | 4.28 | 8.01 | 4.49 | ||||
| EPS | 3.57 | 4.48 | 7.26 | 4.06 | ||||
| DPS | 0.00 | — | 0.00 | 0.00 | ||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 |
SOTAC Company Updates
SOTAC Stock Peers
SOTAC Past Performance & Peer Comparison
SOTAC Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sotac Pharmaceuticals Ltd | 17.91 | 2.91 | — |
| Sun Pharmaceutical Industries Ltd | 36.71 | 5.53 | 0.96% |
| Cipla Ltd | 22.75 | 3.83 | 1.08% |
| Torrent Pharmaceuticals Ltd | 58.69 | 14.78 | 0.18% |
SOTAC Stock Price Comparison
Compare SOTAC with any stock or ETFCompare SOTAC with any stock or ETF
SOTAC
SOTAC Holdings
SOTAC Shareholdings
SOTAC Promoter Holdings Trend
SOTAC Promoter Holdings Trend
SOTAC Institutional Holdings Trend
SOTAC Institutional Holdings Trend
No institutional holdings trend are available
SOTAC Shareholding Pattern
SOTAC Shareholding Pattern
SOTAC Shareholding History
SOTAC Shareholding History
Foreign Institutions
smallcases containing SOTAC stock
smallcases containing SOTAC stock
Looks like this stock is not in any smallcase yet.
SOTAC Events
SOTAC Events
SOTAC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SOTAC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SOTAC Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SOTAC has not given any dividends in last 5 years
SOTAC Dividends
SOTAC Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSOTAC Stock News & Opinions
SOTAC Stock News & Opinions
Articles & Videos
Corporate
Board of Sotac Pharmaceuticals recommends final dividend
Sotac Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 1%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Sotac Pharmaceuticals to convene board meeting
Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Sotac Pharmaceuticals schedules board meeting
Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Sotac Pharmaceuticals AGM scheduled
Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Sotac Pharmaceuticals consolidated net profit rises 34.26% in the June 2024 quarter
Net profit of Sotac Pharmaceuticals rose 34.26% to Rs 1.45 crore in the quarter ended June 2024 as against Rs 1.08 crore during the previous quarter ended June 2023. Sales rose 1.12% to Rs 25.25 crore in the quarter ended June 2024 as against Rs 24.97 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales25.2524.97 1 OPM %8.759.37 - PBDT2.052.11 -3 PBT1.301.50 -13 NP1.451.08 34 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Sotac Pharmaceuticals to conduct board meeting
Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant